TIL (tumor-infiltrating lymphocytes) technology allows you to use your own “tumor-infiltrating lymphocytes” to destroy cancer cells. In melanoma patients, in the removed tumor they often find single cells of their own immune system, which appeared in it to fight cancer. In laboratory conditions, a cell clone is grown from them, prepared for the destruction of melanoma cells. A huge amount of TIL is injected into the patient’s blood along with an immunodrug from the interleukins group.
Treatment of melanoma in Israel using TIL cell immunotherapy is carried out in several clinics.